Atopic dermatitis (AD) and eczema are chronic inflammatory skin diseases characterized by dryness, pruritus, and impairment of the skin barrier. Standard therapy includes emollients, topical corticosteroids, and, when necessary, systemic treatment. Against this background, there is a growing interest in natural remedies that may enhance the anti‑inflammatory and barrier‑stabilizing effects of baseline therapy. Bee products manufactured by TENTORIUM – honey, propolis, bee venom, bee pollen, and bee chitosan – are considered promising adjuncts in the management of AD and eczema.
Scientific rationale: why bee products may work in inflammatory dermatoses
Several studies demonstrate that components of apitherapy exhibit pronounced anti‑inflammatory and immunomodulatory activity.
Bee venom, in experimental models of atopic dermatitis, has been shown to reduce the severity of skin lesions, decrease skin thickness, serum immunoglobulin E levels, and the production of pro‑inflammatory cytokines such as TNF‑α and TSLP, as well as to lower eosinophil and mast cell infiltration.
Honey, particularly manuka honey, when used topically in patients with AD, improved the clinical appearance of lesions, reduced inflammation, and modulated mediators of allergic skin inflammation.
Propolis demonstrates antiseptic and anti‑inflammatory properties, accelerates tissue repair, and contributes to restoration of the epidermal barrier.
It is essential to emphasize that the clinical evidence base for specific commercial brands remains limited; therefore, bee products should be regarded as an adjunct rather than a replacement for conventional dermatologic therapy.
TENTORIUM bee products potentially relevant for AD and eczema
Below is an overview of TENTORIUM products which, based on their composition and presumed mechanisms of action, can reasonably be considered for inclusion in individualized skin support programs for patients with AD and eczema, following consultation with a dermatologist or allergist.
1. “Life Without Allergy” program
On the official TENTORIUM website, the “Life Without Allergy” comprehensive program is presented, including several products based on bee components. Among them:
-
Apihit balm – a natural sorbent containing bee‑derived chitosan, designed to bind and remove toxic and foreign substances from the body, potentially alleviating symptoms in food‑related allergic conditions.
-
Apitok – a combination of honey, propolis, and royal jelly with anti‑inflammatory and antioxidant properties supporting immune function.
For patients with AD and eczema, such a program may be regarded as systemic support aimed at reducing allergen load, facilitating detoxification processes, and providing gentle immunomodulation.
2. Aqueous propolis extract (“APV”)
The aqueous propolis extract TENTORIUM (APV) is widely represented in the brand’s assortment, including 15 ml. In dermatologic practice and in products from other manufacturers, propolis is described as an antiseptic and anti‑inflammatory component that accelerates healing and supports recovery of the epidermis.
Possible directions of use in AD and eczema (subject to medical supervision):
-
Topically – as part of creams and lotions, to help reduce microbial load and inflammation in affected areas.
-
Orally – as a general supportive agent, provided that individual tolerance is verified and contraindications are excluded.
3. Creams containing propolis, honey, and beeswax
Within the TENTORIUM line and in specialized retail, there are skin care creams that include beeswax, propolis, honey, and other natural ingredients.
-
Creams based on beeswax form a protective film, soften the skin, and help restore the epidermal barrier.
-
Propolis provides anti‑inflammatory and antiseptic effects and promotes wound healing.
-
Honey and plant oils improve skin hydration and elasticity.
The “Tentorium” cream is described as a product that improves skin condition, reduces inflammation, itching, and swelling, and accelerates repair of damaged tissues. In AD and eczema, such creams may be particularly useful during remission or subacute phases for the care of dry, irritated skin and for prevention of exacerbations.
4. Products containing bee venom
Topical products with bee venom produced by TENTORIUM are traditionally positioned for musculoskeletal problems, microcirculation disorders, and localized inflammatory conditions. Bee venom is known to have potent anti‑inflammatory and analgesic properties and to improve local blood flow.
Given the high sensitizing potential of bee venom, in patients with AD and eczema such topical products should only be considered on a strictly individualized basis, under specialist supervision and after appropriate skin testing, due to the risk of inducing or aggravating allergic reactions.
Role of bee products in comprehensive patient management
TENTORIUM bee products are best viewed as part of a multi‑level management strategy rather than stand‑alone monotherapy.
Key directions for integration include:
-
Support of the skin barrier: creams with propolis, beeswax, and honey for daily care of dry, damaged skin, especially in inter‑relapse periods.
-
Reduction of inflammation and itch: use of topical products containing anti‑inflammatory bee‑derived components (propolis, honey), in line with data on the anti‑inflammatory effects of apitherapy components in AD.
-
Systemic support: programs containing bee chitosan, honey, propolis, and royal jelly may help decrease toxic and allergen load and support antioxidant defenses and immune regulation.
Essential prerequisites:
-
Individualized treatment planning with involvement of a dermatologist and/or allergist.
-
Careful assessment of the risk of allergy to bee products.
-
Preservation of standard therapy (emollients, topical anti‑inflammatory agents, systemic drugs when indicated) as the foundation of treatment, while bee products remain adjunctive tools.
Bee products from TENTORIUM, including honey, propolis, bee venom, bee pollen, and bee‑derived chitosan, represent a biologically active toolkit that may complement established approaches to the management of atopic dermatitis and eczema. Experimental and early clinical data suggest meaningful anti‑inflammatory, barrier‑restoring, and immunomodulatory effects of apitherapy components, although evidence specific to individual commercial formulations is still limited. In real‑world practice, these products should therefore be used as adjuncts to, rather than substitutes for, guideline‑based dermatologic therapy, with mandatory specialist supervision and strict consideration of individual tolerability and allergy risk. This integrated, personalized strategy allows clinicians and patients to harness the potential benefits of bee‑derived products while maintaining a safe and evidence‑informed standard of care.
